NBTXR3, hafnium oxide nanoparticles in the treatment of liver cancer: A phase I/II trial. Effect of inhibition of 15-PGDH on Kras-driven tumor expansion through all-trans retinoic acid metabolism in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results